ACTAVIS MID ATLANTIC FDA Approval ANDA 075262

ANDA 075262

ACTAVIS MID ATLANTIC

FDA Drug Application

Application #075262

Documents

Letter1999-03-31

Application Sponsors

ANDA 075262ACTAVIS MID ATLANTIC

Marketing Status

Discontinued001

Application Products

001SYRUP;ORALEQ 2MG BASE/5ML0ALBUTEROL SULFATEALBUTEROL SULFATE

FDA Submissions

ORIG1AP1999-03-30

Submissions Property Types

SUPPL1Null0

CDER Filings

ACTAVIS MID ATLANTIC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 75262
            [companyName] => ACTAVIS MID ATLANTIC
            [docInserts] => ["",""]
            [products] => [{"drugName":"ALBUTEROL SULFATE","activeIngredients":"ALBUTEROL SULFATE","strength":"EQ 2MG BASE\/5ML","dosageForm":"SYRUP;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ALBUTEROL SULFATE","submission":"ALBUTEROL SULFATE","actionType":"EQ 2MG BASE\/5ML","submissionClassification":"SYRUP;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.